| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.2M | — | -11.4% |
| Cost of Revenue | $1.6M | — | -16.2% |
| Gross Profit | $1.6M | — | -5.8% |
| R&D Expense | $18K | — | -40.0% |
| SG&A Expense | $1.9M | — | -12.9% |
| Operating Income | -$318K | — | -2990.9% |
| Pre-tax Income | -$643K | — | -530.4% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$643K | — | -489.9% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $391K | -2.7% | -9.1% |
| Inventory | $3.9M | -4.5% | -10.7% |
| Current Assets | $5.0M | -2.7% | -16.2% |
| Total Assets | $6.7M | -3.4% | -13.4% |
| Current Liabilities | $5.2M | +3.6% | -1.4% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $101K | — | +224.7% |
| Capital Expenditures | $3K | — | -92.5% |
| Investing Cash Flow | -$3K | — | +92.5% |
| Financing Cash Flow | -$68K | — | -114.2% |
| Free Cash Flow | $98K | — | +181.0% |
| -100.0% |
| Total Liabilities | $5.2M | -4.9% | -11.0% |
| Stockholders' Equity | $1.5M | +2.0% | -20.8% |